Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro

Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology

Volumn 98, Issue 1, 2010, Pages 19-29

  Trejo, Fernando M ^a   Pérez, Pablo F ^a,b   De Antoni, Graciela L ^a,b,c  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b FACULTAD DE CIENCIAS EXACTAS   (Argentina)

^c Universidad Provincial del Sudoeste   (Argentina)

Author keywords

Bifidobacterium; Clostridium difficile; Lactobacillus; Probiotics; Toxins; Virulence

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; PROBIOTIC AGENT; VIRULENCE FACTOR;

ADSORPTION KINETICS; ANTIBIOSIS; ARTICLE; BACTERIUM CULTURE; BIFIDOBACTERIUM; BIOLOGICAL ACTIVITY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COCULTURE; CONTROLLED STUDY; DRUG SCREENING; INFECTION PREVENTION; LACTOBACILLUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; SUPERNATANT; VERO CELL;

ANTIBIOSIS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; COCULTURE TECHNIQUES; ENTEROTOXINS; PROBIOTICS; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; CLOSTRIDIUM DIFFICILE; LACTOBACILLUS;

EID: 77951667378     PISSN: 00036072     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10482-010-9424-6     Document Type: Article

References (45)

1. P Banerjee GJ Merkel AK Bhunia 2009 Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells Gut Pathog 1 8 19 10.1186/1757-4749-1-8 19397787
2. SD Bélanger M Boissinot N Clairoux FJ Picard MG Bergeron 2003 Rapid detection of Clostridium difficile in feces by Real-time PCR J Clin Microbiol 41 730 734 10.1128/JCM.41.2.730-734.2003 12574274 (Pubitemid 36184188)
3. J Benyacoub PF Pérez F Rochat KY Saudan G Reuteler LN Antille MA Humen GL De Antoni C Cavadini S Blum EJ Schiffrin 2005 Enterococcus faecium strain SF68 improves immune response to Giardia intestinalis in mice J Nutr 135 1171 1176 1:CAS:528:DC%2BD2MXktFKit7k%3D 15867299 (Pubitemid 40638323)
4. I Castagliuolo AC Keates CC Wang A Pasha L Valenick CP Kelly ST Nikulasson JT LaMont C Pothoulakis 1998 Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells J Immunol 160 6039 6045 1:CAS:528:DyaK1cXjvVais7c%3D 9637520 (Pubitemid 28298067)
5. X Chen EG Kokkotou N Mustafa KR Bhaskar S Sougioultzis C Pothoulakis CP Kelly 2006 Saccharomyces boulardii inhibits ERK1/2 mitogen activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis J Biol Chem 281 24449 24454 10.1074/jbc.M605200200 1:CAS:528:DC%2BD28Xot1eqsbg%3D 16816386 (Pubitemid 44274218)
6. MC Collado M Gueimonde M Hernández Y Sanz S Salminen 2005 Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion J Food Prot 68 2672 2678 16355841 (Pubitemid 41752693)
7. JF Colombel A Cortot C Neut C Romond 1987 Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects Lancet 2 43 10.1016/S0140-6736(87)93078-9 1:STN:280:DyaL2s3ls1CmsQ%3D%3D 2885529 (Pubitemid 17083687)
8. SS Dineen AC Villapakkam JT Nordman AL Sonenshein 2007 Repression of Clostridium difficile gene expression by CodY Mol Microbiol 66 206 219 10.1111/j.1365-2958.2007.05906.x 1:CAS:528:DC%2BD2sXhtFeltbnO 17725558 (Pubitemid 47414797)
9. ER Dubberke KA Reske Y Yan MA Olsen LC McDonald VJ Fraser 2007 Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors Clin Infect Dis 45 1543 1549 10.1086/523582 18190314 (Pubitemid 351411837)
10. B Dupuy AL Sonenshein 1998 Regulated transcription of Clostridium difficile toxin genes Mol Microbiol 27 107 120 10.1046/j.1365-2958.1998.00663.x 1:CAS:528:DyaK1cXjtlynuw%3D%3D 9466260 (Pubitemid 28022581)
11. GL Garrote AG Abraham AG De Antoni 2001 Chemical and microbiological characterisation of kefir grains J Dairy Res 68 639 652 10.1017/ S0022029901005210 1:CAS:528:DC%2BD38XjtFKnu7c%3D 11928960 (Pubitemid 33699506)
12. A Gomez Zavaglia G Kociubinski PF Pérez GL De Antoni 1998 Isolation and characterization of Bifidobacterium strains for probiotic formulation J Food Prot 61 865 873 1:STN:280:DyaK1czktlWnsA%3D%3D 9678171 (Pubitemid 28348610)
13. R Govind G Vediyappan RD Rolfe JA Fralik 2006 Evidence that Clostridium difficile TcdC is a membrane-associated protein J Bacteriol 188 3716 3720 10.1128/JB.188.10.3716-3720.2006 1:CAS:528:DC%2BD28XkslClu7c%3D 16672625 (Pubitemid 43726234)
14. S Gursoy K Guven T Arikan A Yurci E Torun M Baskol O Ozbakir M Yucesoy 2007 Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics Hepatogastroenterology 54 1720 1724 1:CAS:528:DC%2BD2sXhtlektLbM 18019703 (Pubitemid 350068463)
15. AA Hugo EJ Kakisu GL De Antoni PF Pérez 2008 Lactobacilli antagonize biological effects of enterohaemorrhagic Escherichia coli in vitro Lett Appl Microbiol 46 613 619 10.1111/j.1472-765X.2008.02363.x 1:STN:280:DC%2BD1czisFGitg%3D%3D 18422938 (Pubitemid 351703901)
16. MA Humen GL De Antoni J Benyacoub ME Costas MI Cardozo L Kozubsky K-Y Saudan A Boenzli-Bruand S Blum EJ Schiffrin PF Pérez 2005 Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo Infect Immun 73 1265 1269 10.1128/IAI.73.2.1265-1269.2005 1:CAS:528:DC%2BD2MXhtVWgtr4%3D 15664978 (Pubitemid 40165795)
17. T Hundsberger V Braun M Weidmann P Leukel M Sauerborn C Von Eichel-Streiber 1997 Transcription analysis or the genes tcdA-E of the pathogenicity locus of Clostridium difficile Eur J Biochem 244 735 742 10.1111/j.1432-1033.1997.t01-1-00735.x 1:CAS:528:DyaK2sXisVersb4%3D 9108241 (Pubitemid 27130508)
18. T Jank T Giesemann K Aktories 2007 Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function Glycobiology 17 15R 22R 10.1093/glycob/cwm004 1:CAS:528:DC%2BD2sXjtlCjtLc%3D 17237138 (Pubitemid 46432006)
19. S Karlsson A Lindberg E Norin LG Burman T Akerlund 2000 Toxins, butyric acid, and short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile Infect Immun 68 5881 5888 10.1128/IAI.68.10.5881-5888.2000 1:STN:280:DC%2BD3M%2FitFWquw%3D%3D 10992498
20. S Karlsson LG Burman T Akerlund 2008 Induction of toxins in Clostridium difficile is associated with dramatic changes of its metabolism Microbiology 154 3430 3436 10.1099/mic.0.2008/019778-0 1:CAS:528:DC%2BD1cXhsVCltbfO 18957596
21. M Kotowska P Albrecht H Szakewska 2005 Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea in children: a randomized double-blind placebo-controlled trial Aliment Pharmacol Ther 21 583 590 10.1111/j.1365-2036.2005.02356.x 1:STN:280:DC%2BD2M7gvFOqtg%3D%3D 15740542 (Pubitemid 40381510)
22. S Lewis S Burmeister J Brazier 2005 Effect of the probiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study Clin Gastroenterol Hepatol 3 442 448 10.1016/S1542-3565(04) 00677-9 1:CAS:528:DC%2BD2MXltVWqtbg%3D 15880313 (Pubitemid 40616909)
23. AP Limaye DK Turgeon BT Cookson TR Fritsche 2000 Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficile J Clin Microbiol 38 696 697
24. DM Lyerly HC Krivan TD Wilkins 1988 Clostridium difficile: its disease and toxins Clin Microbiol Rev 1 1 18 1:STN:280:DyaL1M%2FnslersQ%3D%3D 3144429
25. T Maegawa T Karasawa T Ohta X Wang H Kato H Hayashi S Nakamura 2002 Linkage between toxin production and purine biosynthesis in Clostridium difficile J Med Microbiol 51 34 41 1:CAS:528:DC%2BD38XnsFSrtw%3D%3D 11800470 (Pubitemid 34060131)
26. N Mani B Dupuy 2001 Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor PNAS 98 5844 5849 10.1073/pnas.101126598 1:CAS:528:DC%2BD3MXjs1Wnt78%3D 11320220 (Pubitemid 32435730)
27. S Matsuki E Ozaki M Shozu M Inoue S Shimizu N Yamaguchi T Karasawa T Yamagishi S Nakamura 2005 Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan Int Microbiol 8 43 48 15906260 (Pubitemid 43126754)
28. M Medrano PF Pérez AG Abraham 2008 Kefiran antagonizes cytopathic effects of Bacillus cereus extracellular factors Int J Food Microbiol 122 1 7 10.1016/j.ijfoodmicro.2007.11.046 1:CAS:528:DC%2BD1cXhslOmtLY%3D 18174111 (Pubitemid 351220835)
29. M Medrano MF Hamet AG Abraham PF Pérez 2009 Kefiran protects Caco-2 cells from cytopathic effects induced by Bacillus cereus infection Antonie van Leewenhoek 96 505 513 10.1007/s10482-009-9366-z 1:CAS:528: DC%2BD1MXht12msLvO
30. J Minnaard M Humen PF Pérez 2001 Effect of Bacillus cereus exocellular factors on human intestinal epithelial cells J Food Prot 64 1535 1541 1:CAS:528:DC%2BD3MXnvVGisbw%3D 11601702 (Pubitemid 32972543)
31. J Minnaard V Lievin-Le Moal MH Coconnier AL Servin PF Pérez 2004 Disassembly of F-actin cytoskeleton after interaction of Bacillus cereus with fully differentiated human intestinal Caco-2 cells Infect Immun 72 3106 3112 10.1128/IAI.72.6.3106-3112.2004 1:CAS:528:DC%2BD2cXkslCiur8%3D 15155611 (Pubitemid 38697730)
32. S Nakamura M Mikawa N Tanabe K Yamakawa S Nishida 1982 Effect of clindamycin on cytotoxin production by Clostridium difficile Microbiol Immunol 26 985 992 1:CAS:528:DyaL3sXhtVCiu78%3D 7167065 (Pubitemid 13149082)
33. LE Niers MO Hoekstra HM Timmerman NO van Uden PM de Graaf HH Smits JL Kimpen GT Rijkers 2007 Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells Clin Exp Immunol 149 344 352 10.1111/j.1365-2249.2007.03421.x 1:CAS:528:DC%2BD2sXhtVShs73J 17521319 (Pubitemid 47063056)
34. DP Osgood NP Wood JF Sperry 1993 Nutritional aspects of cytotoxin production by Clostridium difficile Appl Environ Microbiol 59 3985 3988 1:CAS:528:DyaK2cXislagug%3D%3D 8285703
35. PF Perez J Minnaard EA Disalvo GL De Antoni 1998 Surface properties of bifidobacterial strains of human origin Appl Environ Microbiol 64 21 26 1:CAS:528:DyaK1cXitVamsQ%3D%3D 9435057 (Pubitemid 28040286)
36. S Plummer MA Weaver JC Harris P Dee J Hunter 2004 Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea Int Microbiol 7 59 62 15179608 (Pubitemid 38901146)
37. D Rönnqvist U Forsgren-Brusk U Husmark E Grahn-Håkansson 2007 Lactobacillus fermentum Ess-1 with unique growth inhibition of vulvo-vaginal candidiasis pathogens J Med Microbiol 56 1500 1504 10.1099/jmm.0.47226-0 17965352 (Pubitemid 350175077)
38. P Ruas-Madiedo M Gueimonde A Margolles CG de los Reyes-Gavilán S Salminen 2006 Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus J Food Prot 69 2011 2015 1:CAS:528:DC%2BD28XovFyrs74%3D 16924934 (Pubitemid 44384484)
39. J Schirmer K Aktories 2004 Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins Biochim Biophys Acta 1673 66 74 1:CAS:528:DC%2BD2cXltl2htb0%3D 15238250 (Pubitemid 38844795)
40. M Schroeder 2005 Clostridium difficile associated diarrhea Am Fam Physician 71 921 928 15768622
41. M Segarra-Newnham 2007 Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii Ann Pharmacother 41 1284 1287 10.1345/aph.1K228 (Pubitemid 47122568)
42. RH Sunenshine LC McDonald 2006 Clostridium difficile-associated disease: new challenges from an established pathogen Cleve Clin J Med 73 187 197 10.3949/ccjm.73.2.187 16478043
43. FM Trejo J Minnaard PF Pérez GL De Antoni 2006 Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants Anaerobe 12 186 193 10.1016/j.anaerobe.2006.03.004 1:CAS:528:DC%2BD28Xptlyqtr0%3D 16759886 (Pubitemid 44331635)
44. M Wullt ML Hagslatt I Odenholt 2003 Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial Scand J Infect Dis 35 365 367 10.1080/00365540310010985 12953945 (Pubitemid 37038627)
45. K Yamakawa T Karasawa T Ohta H Hayashi S Nakamura 1998 Inhibition of enhanced toxin production by Clostridium difficile in biotin-limited conditions J Med Microbiol 47 767 771 10.1099/00222615-47-9-767 1:CAS:528: DyaK1cXmt1Wjsrg%3D 9736158 (Pubitemid 28401542)